p15PAF, a novel PCNA associated factor with increased expression in tumor tissues

Oncogene

Volumn 20, Issue 4, 2001, Pages 484-489

  Yu, Peiwen ^a   Huang, Betty ^a   Shen, Mary ^a   Lau, Clorinda ^a   Chan, Eva ^a   Michel, Jennifer ^b   Xiong, Yue ^b   Payan, Donald G ^a   Luo, Ying ^a  

^a RIGEL PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

P21; PCNA; PIP box; Tumor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; PROTEIN P15; PROTEIN P21;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; ESOPHAGUS TUMOR; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; TUMOR; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; RNA, MESSENGER; RNA, NEOPLASM; TISSUE DISTRIBUTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0035945643     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204113     Document Type: Article

References (26)